T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$6.08B |
| 2 |
PayPal
PYPL
|
+$722M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$712M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$692M |
| 5 |
Morgan Stanley
MS
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$5.54B |
| 2 |
Vipshop
VIPS
|
+$825M |
| 3 |
Honeywell
HON
|
+$813M |
| 4 |
Estee Lauder
EL
|
+$804M |
| 5 |
GE Aerospace
GE
|
+$787M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.49% |
| 2 | Consumer Discretionary | 15.06% |
| 3 | Financials | 13.94% |
| 4 | Technology | 11.82% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Madison Square Garden
MSGS
$9.94B
| $1.25M | ﹤0.01% |
10,788
-18,884
| -64% | -$2.27M |
|
1627
New Jersey Resources
NJR
$5.64B
| $1.25M | ﹤0.01% |
37,770
+220
| +0.6% | +$6.74K |
|
1628
Rithm Capital
RITM
$5.79B
| $1.23M | ﹤0.01% |
101,175
-19,700
| -16% | -$243K |
|
|
BMR
1629
DELISTED
BIOMED REALTY TRUST INC
BMR
| $1.23M | ﹤0.01% |
51,934
+3,534
| +7% | +$82.2K |
|
|
ABMD
1630
DELISTED
Abiomed Inc
ABMD
| $1.23M | ﹤0.01% |
13,610
+1,610
| +13% | +$137K |
|
1631
Dycom Industries
DY
$12.3B
| $1.23M | ﹤0.01% |
17,553
+90
| +0.5% | +$7.15K |
|
1632
Sarepta Therapeutics
SRPT
$1.95B
| $1.22M | ﹤0.01% |
31,668
+120
| +0.4% | +$3.89K |
|
1633
HUB Group
HUBG
$2.55B
| $1.22M | ﹤0.01% |
73,980
-736,340
| -91% | -$13.7M |
|
1634
SITE Centers
SITC
$158M
| $1.21M | ﹤0.01% |
55,604
+1,432
| +3% | +$30.7K |
|
|
AWH
1635
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $1.2M | ﹤0.01% |
32,295
-505
| -2% | -$18.7K |
|
|
SPN
1636
DELISTED
Superior Energy Services, Inc.
SPN
| $1.2M | ﹤0.01% |
8,885
+913
| +11% | +$136K |
|
|
EXTN
1637
DELISTED
Exterran Corporation
EXTN
| $1.19M | ﹤0.01% |
+74,249
| New | +$1.17M |
|
|
STR
1638
DELISTED
QUESTAR CORP
STR
| $1.19M | ﹤0.01% |
61,190
+4,390
| +8% | +$86.1K |
|
|
ODP
1639
DELISTED
ODP
ODP
| $1.18M | ﹤0.01% |
20,874
+1,373
| +7% | +$91.4K |
|
|
ISBC
1640
DELISTED
Investors Bancorp, Inc.
ISBC
| $1.18M | ﹤0.01% |
94,426
+2,500
| +3% | +$31.5K |
|
1641
Omega Healthcare
OHI
$13.9B
| $1.17M | ﹤0.01% |
33,521
+371
| +1% | +$12.8K |
|
1642
NCR Voyix
VYX
$1.17B
| $1.17M | ﹤0.01% |
77,679
-5,647
| -7% | -$89.9K |
|
|
GLOG
1643
DELISTED
GASLOG LTD
GLOG
| $1.16M | ﹤0.01% |
140,100
+58,100
| +71% | +$624K |
|
|
LSI
1644
DELISTED
Life Storage, Inc.
LSI
| $1.16M | ﹤0.01% |
16,185
+135
| +0.8% | +$9.03K |
|
1645
Charles River Laboratories
CRL
$13.4B
| $1.16M | ﹤0.01% |
14,393
-5,349
| -27% | -$386K |
|
|
FMI
1646
DELISTED
Foundation Medicine, Inc.
FMI
| $1.16M | ﹤0.01% |
54,910
| – | – |
|
|
ENZY
1647
DELISTED
Enzymotec Ltd
ENZY
| $1.16M | ﹤0.01% |
304,445
| – | – |
|
1648
Bank OZK
OZK
$5.7B
| $1.15M | ﹤0.01% |
23,300
+2,600
| +13% | +$131K |
|
|
ALR
1649
DELISTED
Alere Inc
ALR
| $1.15M | ﹤0.01% |
29,416
+1,676
| +6% | +$71.9K |
|
1650
Cracker Barrel
CBRL
$1.31B
| $1.15M | ﹤0.01% |
9,050
+50
| +0.6% | +$6.74K |
|
Similar funds
T. Rowe Price Associates's Q4 2015 Portfolio in Review
As of Q4 2015, T. Rowe Price Associates held 2,616 positions worth $475B, up 5.8% from $449B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2015 filing shows 108 new, 1,286 increased, 995 reduced and 102 closed positions. Its largest new stake was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B. The largest sale was Alphabet (Google) Class C, an estimated $5.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2015 buy was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B.
- T. Rowe Price Associates added most to PayPal in Q4 2015, an estimated $722M increase.
- T. Rowe Price Associates's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $5.54B.
- T. Rowe Price Associates fully exited CYTEC INDS INC in Q4 2015, selling an estimated $610M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $475B portfolio in Q4 2015.
- T. Rowe Price Associates opened 108 new positions and closed 102 in Q4 2015.
- T. Rowe Price Associates's portfolio value rose 5.8% quarter-over-quarter to $475B.
Based on T. Rowe Price Associates's 13F filing for Q4 2015, filed 16 Feb 2016.